USE OF ETANERCEPT IN PATIENTS WITH OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
The article describes a case of torpid course of oligoarticular juvenile idiopathic arthritis (JIA) and the successful use of soluble receptorsf or tumor necrosis factor alpha (TNF) - etanercept - during its treatment. After 4 weeks of treatment the patient returned to normal laboratory indices of t...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2014-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The article describes a case of torpid course of oligoarticular juvenile idiopathic arthritis (JIA) and the successful use of soluble receptorsf or tumor necrosis factor alpha (TNF) - etanercept - during its treatment. After 4 weeks of treatment the patient returned to normal laboratory indices of the disease activity, and the duration of morning stiffness and severity of inflammatory changes in the joints decreased; after 3 months the acute inflammatory changes in the joints disappeared; after 6 months the patient's functional ability restored; and after 9 months the medically induced remission of the disease was recorded. |
|---|---|
| Item Description: | 1682-5527 1682-5535 10.15690/vsp.v13i6.1206 |